The Effects of Antioxidants in Blueberry Powder on Inflammation Induced by a Single High Fat Meal. (FL89)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01594008 |
Recruitment Status :
Completed
First Posted : May 8, 2012
Last Update Posted : March 24, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Inflammation | Other: Breakfast meal with placebo powder Other: Breakfast meal with 2 serving equivalents of blueberries Other: Breakfast meal with 4 serving equivalents of blueberries | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 43 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Basic Science |
Official Title: | Does Blueberry Intake Alleviate Postprandial Lipemia-induced Inflammation? |
Study Start Date : | January 2012 |
Actual Primary Completion Date : | May 2013 |
Actual Study Completion Date : | May 2013 |

- Other: Breakfast meal with placebo powder
Zero serving equivalents (1 serving equivalent = ½ cup fresh raw blueberries) of blueberries in the form of a mixed side dish comprising frozen yogurt, sugar, and placebo powder.
- Other: Breakfast meal with 2 serving equivalents of blueberries
Two serving equivalents (1 serving equivalent = ½ cup fresh raw blueberries) of blueberries in the form of a mixed side dish comprising frozen yogurt, sugar, and freeze-dried blueberry powder.
- Other: Breakfast meal with 4 serving equivalents of blueberries
Four serving equivalents (1 serving equivalent = ½ cup fresh raw blueberries) of blueberries in the form of a mixed side dish comprising frozen yogurt, sugar, and freeze-dried blueberry powder.
- Monocyte activation in whole blood [ Time Frame: Change in activation from 0 to 3.5 hours ]Monocyte activation assay in whole blood will be measured by IL-1Beta secretion and other cytokines (TNF-alpha, INFγ).
- Peripheral blood mononuclear (PBMC) activation [ Time Frame: Change from 0 to 3.5 hours ]Peripheral blood mononuclear (PBMC) activation in response to autologous fasting and postprandial serum will be analyzed for IL-1beta secretion and other cytokines.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy adults
- Able to complete study procedures
- Body Mass Index 18 - 24.9 kg/m2
Exclusion Criteria:
- Diabetes mellitus
- Kidney disease
- Liver disease
- Thyroid disease
- Bleeding disorders
- Autoimmune diseases and other inflammatory disease
- Cancer, unless in remission for > 5 years
- Blood cell counts outside the normal range for age and gender
- Blood chemistry panels outside the normal range for age and gender
- Blood cholesterol greater than 240 mg/dL
- Blood triacylglycerol greater than 300 mg/dL
- Hemoglobin less than 11.5 g/dL
- Hypertension, blood pressure greater than 140/90 mmHg
- Follow a vegetarian diet
- Smoke or use tobacco products
- Drink more than one alcoholic beverage per day
- Taking cholesterol-lowering or blood pressure medication
- Daily or regular use of antihistamines
- Use of nonsteroidal anti-inflammatory drugs (NSAIDs)
- Use of steroids for asthma or other inflammatory diseases
- Use of thyroid-regulating drugs
- Use of over the counter weight loss products
- Known allergies or sensitivities to food ingredients in the test meals
- Taking fish or algal oil supplements and unwilling to stop
- Pregnant and lactating women

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01594008
United States, California | |
USDA, ARS, Western Human Nutrition Research Center | |
Davis, California, United States, 95616 |
Principal Investigator: | Daniel Hwang, PhD | USDA, ARS, Western Human Nutrition Research Center | |
Principal Investigator: | John Rutledge, MD | University of California, Davis |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | USDA, Western Human Nutrition Research Center |
ClinicalTrials.gov Identifier: | NCT01594008 |
Other Study ID Numbers: |
250305-3 |
First Posted: | May 8, 2012 Key Record Dates |
Last Update Posted: | March 24, 2015 |
Last Verified: | May 2013 |
Toll like receptors Inflammation Anthocyanins Blueberries |
Inflammation Pathologic Processes |